acut
respiratori
distress
syndrom
ard
one
chief
condit
patient
admit
intens
care
unit
icu
contribut
substanti
mortal
respiratori
viral
infect
uncommon
critic
ill
patient
receiv
invas
mechan
ventil
due
respiratori
studi
report
frequenc
respiratori
viral
infect
rang
avail
multiplex
revers
chain
reaction
rtpcr
facilit
identif
respiratori
viral
among
divers
risk
factor
ard
respiratori
viral
infect
shown
contribut
develop
progress
pulmonari
although
sever
studi
report
clinic
impact
respiratori
virus
critic
ill
studi
need
clarifi
signific
pulmonari
ard
influenza
viral
infect
pulmonari
ard
gain
attent
intensivist
due
high
morbid
littl
data
compar
characterist
outcom
differ
type
virus
patient
pulmonari
ard
moreov
differ
clinic
outcom
patient
infect
influenza
respiratori
virus
clearli
elucid
aim
studi
compar
characterist
clinic
outcom
patient
pulmonari
ard
infect
influenza
vs
respiratori
virus
patient
diagnos
pulmonari
ard
admit
medic
icu
tertiari
hospit
receiv
invas
mechan
ventil
search
januari
june
ard
fulfil
berlin
diagnost
among
underw
rtpcr
respiratori
viral
infect
review
respiratori
specimen
bronchial
endotrach
aspir
nasopharyng
swab
sputum
obtain
rtpcr
analysi
advansur
rv
realtim
rtpcr
lg
chemistri
seoul
korea
assay
base
multiplex
polymeras
chain
reaction
method
use
identifi
respiratori
virus
influenza
viru
parainfluenza
viru
respiratori
syncyti
viru
adenoviru
metapneumoviru
rhinoviru
bocavriu
coronaviru
baselin
age
sex
bodi
mass
index
comorbid
clinic
characterist
acut
physiolog
chronic
health
evalu
apach
ii
score
sequenti
organ
failur
assess
sofa
score
clinic
complic
shock
acut
kidney
injuri
manag
etc
assess
addit
data
laboratori
neutrophil
count
lymphocyt
count
hemoglobin
platelet
creactiv
protein
crp
level
total
protein
level
albumin
level
etc
microbiolog
data
type
respiratori
viru
corespiratori
bacteri
fungal
pathogen
clinic
outcom
length
stay
icu
hospit
mortal
analyz
studi
approv
institut
review
board
gyeongsang
nation
univers
hospit
inform
consent
waiv
due
retrospect
natur
studi
studi
accord
ethic
standard
institut
andor
nation
research
committe
helsinki
declar
later
amend
compar
ethic
standard
continu
data
express
deviat
sd
compar
use
mannwhitney
u
test
noncontinu
data
express
number
percentag
analyz
use
chisquar
fisher
exact
test
evalu
factor
associ
logist
regress
analysi
use
factor
pvalu
univari
analysi
enter
multivari
analysi
data
analyz
use
spss
softwar
version
spss
inc
chicago
il
usa
one
hundr
sixtyseven
patient
pulmonari
ard
admit
medic
icu
figur
show
flow
patient
ard
period
one
hundr
twentysix
patient
pulmonari
ard
underw
multiplex
rtpcr
evalu
presenc
respiratori
viral
infect
identifi
subject
communityacquir
respiratori
viral
infect
identifi
patient
communityacquir
ard
wherea
hospitalacquir
respiratori
infect
detect
hospitalacquir
ard
mean
age
patient
year
proport
men
case
risk
factor
pulmonari
ard
pneumonia
twentyeight
patient
infect
influenza
viru
respiratori
virus
identifi
patient
tabl
show
characterist
patient
influenza
respiratori
viru
infect
signific
differ
regard
baselin
characterist
sever
ill
clinic
complic
patient
influenza
respiratori
virus
extracorpor
membran
oxygen
ecmo
significantli
use
patient
influenza
viru
respiratori
virus
rescu
therapi
vs
tabl
compar
laboratori
result
radiolog
score
patient
influenza
virus
trend
toward
higher
hemoglobin
crp
level
patient
influenza
respiratori
virus
signific
differ
observ
paramet
two
group
transthorac
echocardiographi
done
patient
admiss
medic
intens
care
unit
evalu
acut
heart
failur
mean
eject
fraction
stress
induc
cardiomyopathi
right
ventricular
dysfunct
featur
three
five
patient
respect
tabl
enlist
type
respiratori
virus
corespiratori
pathogen
patient
pulmonari
ard
influenza
common
viru
case
respiratori
viru
infect
coronaviru
rsv
parainfluenza
viru
rhinoviru
adenoviru
metapneumoviru
bocaviru
isol
overal
corespiratori
pathogen
isol
simultan
patient
influenza
present
significantli
higher
cobacteri
pathogen
respiratori
virus
gramposit
bacteria
coinfect
common
patient
influenza
viru
respiratori
virus
vs
clinic
outcom
present
compar
tabl
patient
influenza
viru
treat
neuraminidas
inhibitor
oseltamivir
peramivir
antivir
agent
administ
respiratori
virus
overal
icu
mortal
hospit
mortal
rate
respect
signific
differ
extub
success
durat
mechan
ventil
mortal
length
stay
icu
hospit
multivari
analysi
associ
mortal
perform
shown
tabl
apach
ii
score
admiss
associ
icu
mortal
influenza
viru
cobacteri
infect
associ
icu
mortal
factor
associ
mortal
shown
tabl
univari
analysi
apach
ii
sofa
low
partial
pressur
oxygenfract
inspir
oxygen
ratio
associ
mortal
apach
ii
associ
mortal
multivari
analysi
fourteen
patient
treat
steroid
reason
use
steroid
treatment
concomit
exacerb
airway
diseas
refractori
septic
shock
adjunct
treatment
ard
might
affect
mortal
ard
patient
respiratori
viral
infect
present
studi
show
approxim
patient
pulmonari
ard
concomit
respiratori
viral
infect
influenza
viru
commonli
isol
corespiratori
infect
frequent
patient
influenza
infect
respiratori
viral
infect
although
patient
influenza
viru
receiv
invas
treatment
ecmo
clinic
outcom
differ
patient
influenza
infect
viral
infect
apach
ii
associ
icu
mortal
patient
pulmonari
ard
ard
common
reason
admiss
icu
critic
ill
patient
onequart
total
number
patient
receiv
mechan
ventil
diagnos
ard
also
contribut
substanti
mortal
variou
risk
factor
associ
ard
pulmonari
ard
frequent
encount
icu
pneumonia
known
common
etiolog
pulmonari
coinfect
respiratori
viru
found
patient
sever
pneumonia
admit
icu
rang
frequenc
respiratori
viral
infect
pulmonari
ard
establish
current
studi
show
similar
frequenc
respiratori
viral
infect
pulmonari
ard
sever
pneumonia
patient
admit
icu
respiratori
virus
play
role
develop
progress
therefor
import
elucid
clinic
signific
patient
pulmonari
ard
sever
studi
report
clinic
outcom
patient
infect
respiratori
virus
receiv
mechan
present
studi
clinic
outcom
differ
patient
infect
influenza
viru
respiratori
virus
similar
clinic
outcom
report
patient
respiratori
syncyti
viru
rhinoviru
compar
influenza
current
studi
comparison
clinic
outcom
respiratori
virus
perform
due
case
except
influenza
viru
apach
ii
score
associ
mortal
patient
ard
infect
respiratori
virus
suggest
sever
ill
impact
overal
clinic
outcom
present
studi
ecmo
frequent
use
patient
influenza
viru
respiratori
viru
sever
studi
report
use
ecmo
case
refractori
hypoxemia
patient
influenzarel
howev
clinic
implic
frequent
applic
ecmo
patient
influenza
viru
interpret
cautious
present
studi
use
ecmo
gener
determin
multipl
factor
includ
sever
ill
comorbid
patient
rather
type
respiratori
current
studi
corespiratori
bacteri
pathogen
half
patient
influenza
current
studi
consist
previou
studi
influenza
viru
infect
commonli
complic
coinfect
bacteria
staphylococcu
aureu
streptococcu
support
use
empir
antibiot
case
ard
infect
influenza
viru
present
studi
sever
limit
first
studi
conduct
singl
center
analyz
data
retrospect
therefor
select
bia
exclud
second
site
obtain
respiratori
sampl
therefor
whether
respiratori
virus
pathogen
accur
distinguish
miss
detect
respiratori
virus
multiplex
rtpcr
rule
third
chang
clinic
decis
identifi
respiratori
virus
evalu
previou
fourth
prone
posit
perform
low
proport
patient
ard
compar
recent
conclus
respiratori
viral
infect
frequent
observ
patient
pulmonari
ard
demonstr
multiplex
rtpcr
patient
influenza
viru
cobacteri
infect
receiv
ecmo
respiratori
virus
without
signific
differ
respect
clinic
outcom
